Evaluation of the Antihyperglycemic Effect of Minor Steviol Glycosides in Normoglycemic and Induced-Diabetic Wistar Rats

Journal of Medicinal Food

Volumn 19, Issue 9, 2016, Pages 844-852

  Aranda González, Irma ^a   Moguel Ordóñez, Yolanda ^b   Chel Guerrero, Luis ^a   Segura Campos, Maira ^a   Betancur Ancona, David ^a  

^a UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^b Mococha Research Station   (Mexico)

Author keywords

Antihyperglycemic; Dulcoside; Rebaudioside; Stevia rebaudiana; Steviol glycosides; Steviolbioside

Indexed keywords

DISTILLED WATER; DULCOSIDE A; GLIBENCLAMIDE; GLUCOSE; GLYCOSIDE; METFORMIN; NICOTINAMIDE; REBAUDIOSIDE B; REBAUDIOSIDE C; REBAUDIOSIDE D; STEVIOL; STEVIOLBIOSIDE; STREPTOZOCIN; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; KAURANE DERIVATIVE; OLIGOSACCHARIDE; PLANT EXTRACT; TRISACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INTRAPERITONEAL GLUCOSE TOLERANCE TEST; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEVIA REBAUDIANA; ANIMAL; AREA UNDER THE CURVE; BLOOD; CHEMISTRY; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PHYTOTHERAPY; REFERENCE VALUE; STEVIA; WISTAR RAT;

ANIMALS; AREA UNDER CURVE; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DITERPENES, KAURANE; GLYCOSIDES; HYPOGLYCEMIC AGENTS; MALE; OLIGOSACCHARIDES; PHYTOTHERAPY; PLANT EXTRACTS; RATS, WISTAR; REFERENCE VALUES; STEVIA; TRISACCHARIDES;

EID: 84988327848     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2016.0014     Document Type: Article

References (31)

1. Goyal SK, Samsher, Goyal RK: Stevia (Stevia rebaudiana) a biosweetener: A review. Int J Food Sci Nutr 2009;61:1-10.
2. Chaturvedula VS, Upreti M, Prakash I: Diterpene glycosides from Stevia rebaudiana. Molecules 2011;16:3552-3562.
3. JECFA: Steviol glycosides. In: Compendium of Food Additive Specifications. FAO JECFA Monographs, 2010, pp. 17-21.
4. Jackson AU, Tata A, Wu C, Perry RH, Haas G, West L, Cooks RG: Direct analysis of Stevia leaves for diterpene glycosides by desorption electrospray ionization mass spectrometry. Analyst 2009;134:867-874.
5. Woelwer-Rieck U, Lankes C, Wawrzun A, Wüst M: Improved HPLC method for evaluation of the major steviol glycosides in leaves of Stevia rebaudiana. Eur Food Res Technol 2010;231: 581-588.
6. FDA: Food and Drugs Administration. GRAS assessment, Maryland, USA, 2008.
7. Jeppesen PB, Gregersen S, Alstrup KK, Hermansen K: Stevioside induces antihyperglycaemic, insulinotropic and glucagonostatic effects in vivo: Studies in the diabetic Goto-Kakizaki (GK) rats. Phytomedicine 2002;9:9-14.
8. Jeppesen PB, Gregersen S, Rolfsen SE, Jepsen M, Colombo M, Agger A, Xiao J, Kruhoffer M, Orntoft T, Hermansen K: Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki rat. Metabolism 2003;52:372-378.
9. Jeppesen PB, Dyrskog SE, Agger A, Gregersen S, Colombo M, Xiao J, Hermansen K: Can stevioside in combination with a soybased dietary supplement be a new useful treatment of type 2 diabetes? An in vivo study in the diabetic goto-kakizaki rat. Rev Diabet Stud 2006;3:189-199.
10. Raskovic A, Mikov M, Skrbic R, Jakovljevic V, Vasovic V, Posa M, Kuhajda K, Kevresan S, Tomic Z, Siladji D: Effect of stevioside and sodium salt of monoketocholic acid on glycemia in normoglycemic and diabetic rats. Eur J Drug Metab Pharmacokinet 2008;33:17-22.
11. Gregersen S, Jeppesen PB, Holst JJ, Hermansen K: Antihyperglycemic effects of stevioside in type 2 diabetic subjects. Metabolism 2004;53:73-76.
12. Chang JC, Wu MC, Liu IM, Cheng, JT: Increase of insulin sensitivity by stevioside in fructose-rich chow-fed rats. Horm Metab Res 2005;37:610-616.
13. Dyrskog SE, Jeppesen PB, Chen J, Christensen LP, Hermansen K: The diterpene glycoside, rebaudioside A, does not improve glycemic control or affect blood pressure after eight weeks treatment in the Goto-Kakizaki rat. Rev Diabet Stud 2005;2:84-91.
14. Maki KC, Curry LL, Reeves MS, Toth, PD, McKennet JM, Farmer MV, McKenney JM, Toth PD, Schwartz SL, Lubin BC, DicklinMR, BoileauAC,Bisognano JD:Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus. Food Chem Toxicol 2008;46:S47-S53.
15. Official Journal of the Federation. NOM-062-ZOO-1999. Specifications Techniques for the Care and Use of Laboratory Animals. Mexican Official Standard 2001.
16. Masiello P, Broca C, Gross R, Roye M, Manteguetti M, Hillaire-Buys D, Novelli M, Ribes G: Experimental NIDDM: Development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998;47:224-229.
17. Burcelin R: The gut-brain axis: A major glucoregulatory player. Diabetes Metab 2010;36 Suppl 3:S54-S58.
18. Allison DB, Paultre F, Maggio C, Mezzitis N, Pi-Sunyer X: The use of areas under curves in diabetes research. Diabetes Care 1995;18:245-250.
19. Gannon MC, Nuttal FQ, Westphal SA, Neil BJ, Seaquist ER: Effects of dose of ingested glucose on plasma metabolite and hormone responses in type II diabetic subjects. Diabetes Care 1989;12:544-552.
20. Cheng AY, Fantus IG: Oral antihyperglycemic therapy for type 2 diabetes mellitus. CMAJ 2005;172:213-226.
21. Nichols CG, Koster JC, Remedi MS: Beta-cell hyperexcitability: From hyperinsulinism to diabetes. Diabetes Obes Metab 2007; 9:81-88.
22. Rustenbeck I, Wienbergen A, Bleck C, Jorns A: Desensitization of insulin secretion by depolarizing insulin secretagogues. Diabetes 2004;53:Suppl 3:S140-S150.
23. Phillips PJ, Twigg SM: Oral hypoglycaemics-a review of the evidence. Aust Fam Physician 2010;39:651-653.
24. Tahara A, Matsuyama-Yokono A, Nakano R, Someya Y, Shibasaki M: Effects of antidiabetic drugs on glucose tolerance in streptozotocin-nicotinamide-induced mildly diabetic and streptozotocin-induced severely diabetic mice. Horm Metab Res 2008;40:880-886.
25. Tahara A, Matsuyama-Yokono A, Shibasaki M: Effects of antidiabetic drugs in high-fat diet and streptozotocin-nicotinamideinduced type 2 diabetic mice. Eur J Pharmacol 2011;655:108-116.
26. Szkudelski T: The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 2001;50:536-546.
27. Cekic V, Vasovic V, Jakovljevic V, Mikov M, Sabo A: Hypoglycaemic action of stevioside and small a, Cyrillic barley and brewer's yeast based preparation in the experimental model on mice. Bosn J Basic Med Sci 2011;11:11-16.
28. Jeppesen PB, Gregersen S, Poulsen CR, Hermansen K: Stevioside acts directly on pancreatic beta cells to secrete insulin: Actions independent of cyclic adenosine monophosphate and adenosine triphosphate-sensitive K+-channel activity. Metabolism 2000;49:208-214.
29. American Diabets Association. Approaches to glycemic treatment. Sec. 7 in Standards of Medical Care in Diabetes. Diabetes Care 2015;38(Suppl. 1):S41-S48.
30. Chen J, Jeppesen PB, Abudula R, Dyrskog SE, Colombo M, Hermansen K: Stevioside does not cause increased basal insulin secretion or beta-cell desensitization as does the sulphonylurea, glibenclamide: Studies in vitro. Life Sci 2006;78:1748-1753.
31. Aranda-González I, Barbosa-Mar?n E, Toraya-Avilés R, Segura-Campos M, Betancur-Ancona D: Evaluación de la inocuidad de Stevia rebaudiana Bertoni cultivada en el sureste de México como edulcorante de alimentos. Nutr Hosp 2014;30:594-601.